Search

Page, Kathleen, Stephanie Dejardin, Ronald Kahn, Rohit Kulkarni, Kevan Herold, and Silvio Inzucchi. 2007. “A Patient With Type B Insulin Resistance Syndrome, Responsive to Immune Therapy”. Nat Clin Pract Endocrinol Metab 3 (12): 835-40.

Pospisilik, Andrew, Claude Knauf, Nicholas Joza, Paule Benit, Michael Orthofer, Patrice Cani, Ingo Ebersberger, et al. 2007. “Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes”. Cell 131 (3): 476-91.

Fink, Brian, Judy Herlein, Katrine Almind, Saverio Cinti, Ronald Kahn, and William Sivitz. 2007. “Mitochondrial Proton Leak in Obesity-Resistant and Obesity-Prone Mice”. Am J Physiol Regul Integr Comp Physiol 293 (5): R1773-80.

Könner, Christine, Ruth Janoschek, Leona Plum, Sabine Jordan, Eva Rother, Xiaosong Ma, Chun Xu, et al. 2007. “Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production”. Cell Metab 5 (6): 438-49.

Magré, Delépine, Khallouf, Gedde-Dahl, Van Maldergem, Sobel, Papp, et al. 2001. “Identification of the Gene Altered in Berardinelli-Seip Congenital Lipodystrophy on Chromosome 11q13”. Nat Genet 28 (4): 365-70.

Kim, Zisman, Fillmore, Peroni, Kotani, Perret, Zong, et al. 2001. “Glucose Toxicity and the Development of Diabetes in Mice With Muscle-Specific Inactivation of GLUT4”. J Clin Invest 108 (1): 153-60.

Flier, Kulkarni, and Kahn. 2001. “Evidence for a Circulating Islet Cell Growth Factor in Insulin-Resistant States”. Proc Natl Acad Sci U S A 98 (13): 7475-80.

Ristow, Pfister, Yee, Schubert, Michael, Zhang, Ueki, Michael, Lowell, and Kahn. 2000. “Frataxin Activates Mitochondrial Energy Conversion and Oxidative Phosphorylation”. Proc Natl Acad Sci U S A 97 (22): 12239-43.

Hebinck, Hardt, Schöls, Vorgerd, Briedigkeit, Kahn, and Ristow. 2000. “Heterozygous Expansion of the GAA Tract of the X25/Frataxin Gene Is Associated With Insulin Resistance in Humans”. Diabetes 49 (9): 1604-7.

Michael, Kulkarni, Postic, Previs, Shulman, Magnuson, and Kahn. 2000. “Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction”. Mol Cell 6 (1): 87-97.